Welcome to Novo Nordisk in the United States

print email
Latest News
Oct 31, 2018

Bagsværd, Denmark, 31 October 2018 ­– Novo Nordisk today announced the expansion of its biopharm business with an agreement to acquire the US and Canadian rights to Macrilen™ (macimorelin),...

Oct 22, 2018

Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) approved an updated label for Saxenda® (liraglutide) injection 3 mg. The label now includes some data from the...

Download Center

Visit the download center to download Novo Nordisk video and more

Stay Connected

Sign up to receive our new alerts
via e-mail